CN111465857A - 诊断早期心力衰竭的方法 - Google Patents

诊断早期心力衰竭的方法 Download PDF

Info

Publication number
CN111465857A
CN111465857A CN201880063136.3A CN201880063136A CN111465857A CN 111465857 A CN111465857 A CN 111465857A CN 201880063136 A CN201880063136 A CN 201880063136A CN 111465857 A CN111465857 A CN 111465857A
Authority
CN
China
Prior art keywords
biomarker
heart failure
subject
concentration
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880063136.3A
Other languages
English (en)
Chinese (zh)
Inventor
C·普雅德拉
X·汉格
B·舒尔茨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queensland University of Technology QUT
Original Assignee
Queensland University of Technology QUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017903138A external-priority patent/AU2017903138A0/en
Application filed by Queensland University of Technology QUT filed Critical Queensland University of Technology QUT
Publication of CN111465857A publication Critical patent/CN111465857A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Electrotherapy Devices (AREA)
CN201880063136.3A 2017-08-08 2018-08-08 诊断早期心力衰竭的方法 Pending CN111465857A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017903138 2017-08-08
AU2017903138A AU2017903138A0 (en) 2017-08-08 Methods for Diagnosis of Early Stage Heart Failure
PCT/AU2018/050827 WO2019028507A1 (en) 2017-08-08 2018-08-08 METHODS OF DIAGNOSING PRECOCUS STAGES OF CARDIAC INSUFFICIENCY

Publications (1)

Publication Number Publication Date
CN111465857A true CN111465857A (zh) 2020-07-28

Family

ID=65273054

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880063136.3A Pending CN111465857A (zh) 2017-08-08 2018-08-08 诊断早期心力衰竭的方法

Country Status (6)

Country Link
US (1) US20200174021A1 (https=)
EP (1) EP3665483A4 (https=)
JP (1) JP7414281B2 (https=)
CN (1) CN111465857A (https=)
AU (2) AU2018315056B2 (https=)
WO (1) WO2019028507A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024007778A1 (zh) * 2022-07-05 2024-01-11 上海交通大学医学院附属上海儿童医学中心 一种血浆分子标志物犬尿氨酸在早期心力衰竭检测中的应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021245459A1 (en) * 2020-06-03 2021-12-09 Esn Cleer Biomarker identification for imminent and/or impending heart failure
EP4356142A4 (en) 2021-06-16 2025-07-23 Endothelium Scanning Nanotechnology Ltd BIOMARKERS AND DRUG COMBINATIONS FOR THE PREDICTION OF HEART FAILURE

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061131A2 (en) * 2000-12-04 2002-08-08 Bristol-Myers Squibb Company Human single nucleotide polymorphisms
WO2002094870A2 (en) * 2000-11-02 2002-11-28 Curagen Corporation Proteins and nucleic acids encoding same
US20040033582A1 (en) * 2002-06-03 2004-02-19 Manling-Ma Edmonds Human single nucleotide polymorphisms
CN1703523A (zh) * 2002-09-30 2005-11-30 肿瘤疗法科学股份有限公司 诊断前列腺癌的方法
WO2006008002A2 (en) * 2004-07-23 2006-01-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with kallikrein 1 (klk1)
CN101031640A (zh) * 2004-07-29 2007-09-05 干细胞创新有限公司 干细胞的分化
WO2008000067A1 (en) * 2006-06-26 2008-01-03 Vasogen Ireland Limited Treatment of mild chronic heart failure in human patients
US20080057590A1 (en) * 2006-06-07 2008-03-06 Mickey Urdea Markers associated with arteriovascular events and methods of use thereof
US20080300170A1 (en) * 2006-09-01 2008-12-04 Cohava Gelber Compositions and methods for diagnosis and treatment for type 2 diabetes
CN101340928A (zh) * 2005-10-21 2009-01-07 催化剂生物科学公司 抑制补体激活的修饰的蛋白酶
CN101517074A (zh) * 2006-07-05 2009-08-26 催化剂生物科学公司 蛋白酶筛选方法及由此鉴别的蛋白酶
CN101617227A (zh) * 2006-11-30 2009-12-30 纳维哲尼克斯公司 遗传分析系统和方法
US20100267052A1 (en) * 2006-09-01 2010-10-21 American Type Culture Collection Compositions and methods for diagnosis and treatment of type 2 diabetes
US20120219943A1 (en) * 2011-02-03 2012-08-30 Abbott Laboratories Methods of prognosis and diagnosis in chronic heart failure
CN102858985A (zh) * 2009-07-24 2013-01-02 西格马-奥尔德里奇有限责任公司 基因组编辑方法
US20130116343A1 (en) * 2010-04-21 2013-05-09 Board Of Regents Of The University Of Texas System Salivary Protein Markers for Detection of Breast Cancer
CN103289980A (zh) * 2006-07-05 2013-09-11 催化剂生物科学公司 蛋白酶筛选方法及由此鉴别的蛋白酶
CN103642902A (zh) * 2006-11-30 2014-03-19 纳维哲尼克斯公司 遗传分析系统和方法
WO2014193999A2 (en) * 2013-05-28 2014-12-04 Caris Science, Inc. Biomarker methods and compositions
US20150291966A1 (en) * 2012-07-25 2015-10-15 The Broad Institute, Inc. Inducible dna binding proteins and genome perturbation tools and applications thereof
WO2016134365A1 (en) * 2015-02-20 2016-08-25 The Johns Hopkins University Biomarkers of myocardial injury
US20170051053A1 (en) * 2011-12-28 2017-02-23 Immunoqure Ag Method of providing monoclonal auto-antibodies with desired specificity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005110602A (ja) * 2003-10-09 2005-04-28 Sumitomo Pharmaceut Co Ltd アトピー性皮膚炎の疾患マーカー及びその利用
EP1722232A1 (en) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
JP2009541287A (ja) * 2006-06-20 2009-11-26 リポペプチド・アクチエボラーグ 抗癌剤としてのカテリシジン抗菌タンパク質（ｈＣＡＰ１８）の使用
WO2013083781A2 (en) * 2011-12-08 2013-06-13 Pronota N.V. Biomarkers and test panels useful in systemic inflammatory conditions
US20150072360A1 (en) * 2011-12-14 2015-03-12 The Johns Hopkins University Biomarkers of pulmonary hypertension
WO2014028734A1 (en) * 2012-08-15 2014-02-20 The Procter & Gamble Company Human ex vivo skin model and use in methods of identifying modulators of skin inflammation
CN104049082B (zh) * 2014-05-30 2016-03-16 华中科技大学同济医学院附属同济医院 人组织激肽释放酶活性检测试剂盒及其应用
CN105987998B (zh) * 2015-01-30 2017-12-29 江苏众红生物工程创药研究院有限公司 人组织激肽释放酶1elisa定量检测试剂盒

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002094870A2 (en) * 2000-11-02 2002-11-28 Curagen Corporation Proteins and nucleic acids encoding same
WO2002061131A2 (en) * 2000-12-04 2002-08-08 Bristol-Myers Squibb Company Human single nucleotide polymorphisms
US20040033582A1 (en) * 2002-06-03 2004-02-19 Manling-Ma Edmonds Human single nucleotide polymorphisms
CN1703523A (zh) * 2002-09-30 2005-11-30 肿瘤疗法科学股份有限公司 诊断前列腺癌的方法
WO2006008002A2 (en) * 2004-07-23 2006-01-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with kallikrein 1 (klk1)
CN101031640A (zh) * 2004-07-29 2007-09-05 干细胞创新有限公司 干细胞的分化
CN101340928A (zh) * 2005-10-21 2009-01-07 催化剂生物科学公司 抑制补体激活的修饰的蛋白酶
US20080057590A1 (en) * 2006-06-07 2008-03-06 Mickey Urdea Markers associated with arteriovascular events and methods of use thereof
WO2008000067A1 (en) * 2006-06-26 2008-01-03 Vasogen Ireland Limited Treatment of mild chronic heart failure in human patients
CN101517074A (zh) * 2006-07-05 2009-08-26 催化剂生物科学公司 蛋白酶筛选方法及由此鉴别的蛋白酶
CN103289980A (zh) * 2006-07-05 2013-09-11 催化剂生物科学公司 蛋白酶筛选方法及由此鉴别的蛋白酶
US20100267052A1 (en) * 2006-09-01 2010-10-21 American Type Culture Collection Compositions and methods for diagnosis and treatment of type 2 diabetes
US20080300170A1 (en) * 2006-09-01 2008-12-04 Cohava Gelber Compositions and methods for diagnosis and treatment for type 2 diabetes
CN103642902A (zh) * 2006-11-30 2014-03-19 纳维哲尼克斯公司 遗传分析系统和方法
CN101617227A (zh) * 2006-11-30 2009-12-30 纳维哲尼克斯公司 遗传分析系统和方法
CN102858985A (zh) * 2009-07-24 2013-01-02 西格马-奥尔德里奇有限责任公司 基因组编辑方法
US20130116343A1 (en) * 2010-04-21 2013-05-09 Board Of Regents Of The University Of Texas System Salivary Protein Markers for Detection of Breast Cancer
US20120219943A1 (en) * 2011-02-03 2012-08-30 Abbott Laboratories Methods of prognosis and diagnosis in chronic heart failure
CN103403554A (zh) * 2011-02-03 2013-11-20 雅培制药有限公司 慢性心力衰竭的预后和诊断方法
US20170051053A1 (en) * 2011-12-28 2017-02-23 Immunoqure Ag Method of providing monoclonal auto-antibodies with desired specificity
US20150291966A1 (en) * 2012-07-25 2015-10-15 The Broad Institute, Inc. Inducible dna binding proteins and genome perturbation tools and applications thereof
WO2014193999A2 (en) * 2013-05-28 2014-12-04 Caris Science, Inc. Biomarker methods and compositions
WO2016134365A1 (en) * 2015-02-20 2016-08-25 The Johns Hopkins University Biomarkers of myocardial injury

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
ANNE, PIZARD;CHRISTINE, RICHER;NADINE, BOUBY;NICOLAS, PICARD;PIERRE, MENETON;MICHEL, AZIZI;FRAN?OIS, ALHENC-GELAS: "Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney.", BIOLOGICAL CHEMISTRY, vol. 389, 31 December 2008 (2008-12-31) *
CHING-YUN, CHANG;PAOLA, PICOTTI;RUTH, HÜTTENHAIN;VIOLA, HEINZELMANN-SCHWARZ;MARKO, JOVANOVIC;RUEDI, AEBERSOLD;OLGA, VITEK: "Protein significance analysis in selected reaction monitoring (SRM) measurements.", MOLECULAR & CELLULAR PROTEOMICS, vol. 11, 31 December 2012 (2012-12-31) *
TIMOTHY CLOUGH, ET AL.: "Statistical protein quantification and significance analysis in label-free LC-MS experiments with complex designs.", BMC BIOINFORMATICS, vol. 13, 31 December 2012 (2012-12-31) *
XI, ZHANG;TERRY, WALSH;JOHN J, ATHERTON;KARAM, KOSTNER;BENJAMIN, SCHULZ;CHAMINDIE, PUNYADEERA: "Identification and Validation of a Salivary Protein Panel to Detect Heart Failure Early.", THERANOSTICS, vol. 7, no. 18, 26 September 2017 (2017-09-26), XP055794321, DOI: 10.7150/thno.21727 *
余惠珍;谢良地;朱鹏立;许昌声;王华军;李体远;: "人KLK1和EGFP双顺反子重组腺病毒构建及其在血管平滑肌细胞中的表达", 中国病理生理杂志, no. 02, 15 February 2008 (2008-02-15) *
庄伟;谢良地;许昌声;王华军;沈逸华;陈明;: "脂肪组织基质血管组分移植抑制阿霉素诱导的心力衰竭大鼠心肌重构", 福建医科大学学报, no. 05, 28 October 2013 (2013-10-28) *
张乐;胡中扬;杨杰;李蜀渝;曾艺;刘宝琼;杜小平;夏健;刘运海;许宏伟;杨期东;: "KLK1基因rs3212855和rs5515多态性与长沙地区汉族人群脑出血的关联研究", 中南大学学报(医学版), no. 12, 15 December 2010 (2010-12-15) *
张淑群, 强水云, 王西京, 纪宗正, 李妙羡: "血清T-PSA和F-PSA检测在乳腺癌诊断中的意义", 中国肿瘤临床, no. 17, 25 May 2005 (2005-05-25) *
王燕;高友鹤;: "微小病变性肾病早期差异尿蛋白质组分析", 基础医学与临床, no. 03, 5 March 2010 (2010-03-05) *
王锦霞;常乘;马洁;吴松锋;庄举娟;朱云平;: "基于质谱技术筛选差异表达蛋白的统计学策略研究进展", 中国科学:生命科学, no. 04, 20 April 2015 (2015-04-20) *
章文莉;苏津自;: "激肽释放酶-激肽系统对心血管系统的保护作用", 实用老年医学, no. 04, 20 August 2007 (2007-08-20) *
陈清标;蔡超;陈佳鸿;秦国强;陈锡彬;王月生;梁宇翔;韩兆冬;毕学成;钟惟德;: "纳米金标芯片检测用于前列腺癌多基因诊断的实验研究", 现代泌尿生殖肿瘤杂志, no. 01, 22 February 2011 (2011-02-22) *
鲍丹;吕丹;董伟;陈炜;路迎冬;张连峰;: "转基因表达KLK1抵抗压力负荷引起的心室重构", 中国分子心脏病学杂志, no. 03, 25 June 2013 (2013-06-25) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024007778A1 (zh) * 2022-07-05 2024-01-11 上海交通大学医学院附属上海儿童医学中心 一种血浆分子标志物犬尿氨酸在早期心力衰竭检测中的应用

Also Published As

Publication number Publication date
EP3665483A1 (en) 2020-06-17
US20200174021A1 (en) 2020-06-04
AU2021232662A1 (en) 2021-10-07
EP3665483A4 (en) 2021-07-14
AU2021232662B2 (en) 2023-06-01
AU2018315056A1 (en) 2020-03-26
AU2018315056B2 (en) 2021-06-17
JP7414281B2 (ja) 2024-01-16
JP2020530120A (ja) 2020-10-15
WO2019028507A1 (en) 2019-02-14

Similar Documents

Publication Publication Date Title
EP2353011B1 (en) Biomarker for the prediction of first adverse events
CN110431425B (zh) proADM作为指示不良事件的标志物
CN104303061B (zh) 患有疑似慢性心力衰竭的患者中不良事件的预后
CN109564225B (zh) 作为指示不良事件的标志物的组蛋白和/或proADM
AU2021232662B2 (en) Markers relating to early stage heart failure
CN101939651A (zh) 用于检测严重有害的心血管和脑血管事件的方法
US20150072360A1 (en) Biomarkers of pulmonary hypertension
US11740245B2 (en) Mass spectrometry-based methods for the detection of circulating histones H3 and H2B in plasma from sepsis or septic shock (SS) patients
JP6595641B2 (ja) 心不全の診断
US10557860B2 (en) Circulating pulmonary hypertension biomarker
JP2020064051A (ja) 神経変性疾患の診断用ペプチドマーカー
JP5090332B2 (ja) 炎症及び感染症のためのバイオマーカーとしての短鎖ｓｒｌアルコールデヒドロゲナーゼ（ｄｈｒｓ４）の測定
US20210080458A1 (en) Means and methods for determining risk of type-1 diabetes by serum protein biomarkers
Elmas et al. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease
US20130236917A1 (en) Albumin-bound protein/peptide complex as a biomarker for disease
US20240418729A1 (en) Method for detection and quantification of immunoglobulin free light chain dimers
JP2021018124A (ja) 乳がんに関するペプチドマーカー
HK40017069B (en) Proadm as marker indicating an adverse event
HK1203611B (en) Prognosis of adverse events in patients with suspected chronic heart failure

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
AD01 Patent right deemed abandoned

Effective date of abandoning: 20250221